FarmPharma signs an agreement with All-Russian Research Institute of Experimental Veterinary Medicine

Today FarmPharma AB signed a collaboration agreement with Federal Scientific Centre – All-Russian Scientific Research Institute of Experimental Veterinary Medicine named after K. I. Skryabin and Y. R. Kovalenko of the Russian Academy of Sciences (Федеральный научный центр – Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. К. И. Скрябина и Я. Р. Коваленко Российской Академии Наук (ФГБНУ ФНЦ ВИЭВ РАН).

The aim of this project is to measure the activity of bovine interferons produced by FarmPharma in partnership with Karolinska Institutet and select the most promising candidates for further in vitro validation against a collection of bovine pathogens. The work on the project is scheduled to start immediately.

“We are confident that this agreement will be the beginning of a fruitful collaboration that will contribute to the development of InterferOx, – comments Irina Zaitseva, CEO of FarmPharma – This is a huge step in the in vitro development of our project, that will lead to the finalisation of the lead candidate formulation.”

More about All-Russian Scientific Research Institute of Experimental Veterinary Medicine:

The institute conducts fundamental research in the field of virology, microbiology and biotechnology and is also engaged in the development of new generation biological products, technologies and methods for their application to combat especially dangerous infectious and parasitic diseases of animals.

The aim of this project is to measure the activity of bovine interferons produced by FarmPharma in partnership with Karolinska Institutet and select the most promising candidates for further in vitro validation against a collection of bovine pathogens. The work on the project is scheduled to start immediately.

“We are confident that this agreement will be the beginning of a fruitful collaboration that will contribute to the development of InterferOx, – comments Irina Zaitseva, CEO of FarmPharma – This is a huge step in the in vitro development of our project, that will lead to the finalisation of the lead candidate formulation.”

All-Russian Scientific Research Institute:

http://viev.ru/

More about FarmPharma:

FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.

Video presentation:

https://youtu.be/e1cPSC2PC70

Follow us on:

LinkedIn

FarmPharma signs an agreement with All-Russian Research Institute of Experimental Veterinary Medicine

Today FarmPharma AB signed a collaboration agreement with Federal Scientific Centre – All-Russian Scientific Research Institute of Experimental Veterinary Medicine named after K. I. Skryabin and Y. R. Kovalenko of the Russian Academy of Sciences (Федеральный научный центр – Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. К. И. Скрябина и Я. Р. Коваленко Российской Академии Наук (ФГБНУ ФНЦ ВИЭВ РАН).

The aim of this project is to measure the activity of bovine interferons produced by FarmPharma in partnership with Karolinska Institutet and select the most promising candidates for further in vitro validation against a collection of bovine pathogens. The work on the project is scheduled to start immediately.

“We are confident that this agreement will be the beginning of a fruitful collaboration that will contribute to the development of InterferOx, – comments Irina Zaitseva, CEO of FarmPharma – This is a huge step in the in vitro development of our project, that will lead to the finalisation of the lead candidate formulation.”

More about All-Russian Scientific Research Institute of Experimental Veterinary Medicine:

The institute conducts fundamental research in the field of virology, microbiology and biotechnology and is also engaged in the development of new generation biological products, technologies and methods for their application to combat especially dangerous infectious and parasitic diseases of animals.

The aim of this project is to measure the activity of bovine interferons produced by FarmPharma in partnership with Karolinska Institutet and select the most promising candidates for further in vitro validation against a collection of bovine pathogens. The work on the project is scheduled to start immediately.

“We are confident that this agreement will be the beginning of a fruitful collaboration that will contribute to the development of InterferOx, – comments Irina Zaitseva, CEO of FarmPharma – This is a huge step in the in vitro development of our project, that will lead to the finalisation of the lead candidate formulation.”

All-Russian Scientific Research Institute:

http://viev.ru/

More about FarmPharma:

FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.

Video presentation:

https://youtu.be/e1cPSC2PC70

Follow us on:

LinkedIn